Perspective Therapeutics Receivables

Perspective Therapeutics (ISR) currently reports a receivables of $58K as of March 2026. That compares with $78K in the prior-year period — down 25.6% year over year. Use the charts on this page to explore Perspective Therapeutics's receivables history and peer comparisons.

Perspective Therapeutics's receivables decreased from $78K to $58K — a 25.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Perspective Therapeutics reported $58K in receivables as of March 2026. That compares with $78K in the prior-year period — down 25.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $58K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Perspective Therapeutics, and consider following ISR for alerts when major investors trade the stock.

Perspective Therapeutics is classified in the Industrials sector. On receivables, it currently shows $58K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing ISR with unrelated industries.